Home/Filings/4/0001209191-17-009197
4//SEC Filing

Epizyme, Inc. 4

Accession 0001209191-17-009197

CIK 0001571498operating

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 5:55 PM ET

Size

5.5 KB

Accession

0001209191-17-009197

Insider Transaction Report

Form 4
Period: 2017-02-08
Graf Susan E
Chief Business Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-02-08+109,866109,866 total
    Exercise: $12.45Exp: 2027-02-07Common Stock (109,866 underlying)
Footnotes (1)
  • [F1]This option was granted on February 8, 2017 pursuant to the Company's 2013 Stock Incentive Plan with respect to 109,866 shares of Common Stock, with 25% vesting on February 8, 2018 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.

Issuer

Epizyme, Inc.

CIK 0001571498

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001571498

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 5:55 PM ET
Size
5.5 KB